NIH launches clinical study into mixed COVID-19 vaccine schedule
The National Institutes of Health yesterday announced the start of a phase 1/2 clinical trial to investigate the safety and immunogenicity of mixed boosted COVID-19 vaccination regimens. Fully-vaccinated trial participants will receive booster doses of different COVID-19 vaccines and then be followed for one year to allow for the evaluation of safety and other post-vaccination side effects. The initial trial results are expected in late summer 2021.
Related News Articles
Headline
AHA's latest social media toolkit for encouraging vaccination against the flu and COVID-19 provides fall-themed social media posts and graphics. Download the…
Headline
The Centers for Disease Control and Prevention last week endorsed a recommendation for people aged 65 and older and for immunocompromised individuals to…
Headline
The Centers for Disease Control and Prevention is reminding clinicians and other health care workers to take necessary steps to keep themselves and their…
Chairperson's File
Autumn is here, and that means cooler weather and also the start of flu season.We know the best way to prevent influenza is to get a flu vaccine. The Centers…
Headline
The National Foundation for Infectious Diseases Sept. 25 released a survey showing that less than one in five U.S. adults are concerned about themselves or a…
Headline
The Food and Drug Administration Aug. 22 granted emergency use authorization for two new combined COVID-19 and influenza tests. The Nano-Check Influenza-COVID-…